EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis

Fernando Ambriz-Barrera, Ernesto Rojas-Jiménez, Clara Estela Díaz-Velásquez, Aldo Hugo De-La-Cruz-Montoya, Héctor Martínez-Gregorio, Miguel Ruiz-De-La-Cruz, Antonio Huertas, Ana Lorena Montealegre, Carlos Castro-Rojas iD, Gabriela Acosta, Felipe Vaca-Paniagua iD, Sandra Perdomo

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0308176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Fernando Ambriz-Barrera und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztaca…. Hauptthemen laut MEDLINE: Breast Neoplasms, Whole Genome Sequencing, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, UNAM PAPIIT, CONACYT Fondo Sectorial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) has different molecular subgroups related to different risks and treatments. Tumor biopsies for BC detection are invasive and may not reflect tumor heterogeneity. Liquid biopsies have become relevant because they might overcome these limitations. We rationalize that liquid cfDNA biopsies through shallow whole genome sequencing (sWGS) could improve the detection of tumor alterations, complementing the genomic profiling. We evaluated the feasibility to detect somatic copy number alterations (SCNAs) in BC using shallow whole genome sequencing (sWGS) in cfDNA from archived samples from National Cancer Institute of Colombia patients. We sequenced tumor tissues from 38 BC patients with different molecular subtypes using a gene panel of 176 genes significantly mutated in cancer, and by liquid biopsies using sWGS on 20 paired samples to detect SCNAs and compare with the tumor samples. We identified an extensive intertumoral heterogeneity between the molecular subtypes of BC, with a mean tumor load of 602 mutations in the gene panel of tumor tissues. There was a 12.3% of concordance in deletions in the cfDNA-tumor pairs considering only the genes covered by the panel encompassing seven genes: BRCA1 , CDK12 , NF1 , MAP2K4 , NCOR1 , TP53 , and KEAP1 in three patients. This study shows the feasibility to complement the genomic analysis of tumor tissue biopsies to detect SCNA in BC using sWGS in cfDNA, providing a wider identification of potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsWhole Genome SequencingMutationHumansFemaleMiddle AgedDNA Copy Number VariationsAdultAgedBiomarkers, TumorCirculating Tumor DNACell-Free Nucleic Acids

Substanzen

Biomarkers, TumorCirculating Tumor DNACell-Free Nucleic Acids

Autor:innen und Institutionen

  • Laboratorio Nacional en Salud, Diagnóstico Molecular y Efecto Ambiental en Enfermedades Crónico-Degenerativas, Facultad de Estudios Superiores Iztacala, Tlalnepantla, México.
  • Unidad de Investigación en Biomedicina, Facultad de Estudios Superiores Iztacala, UNAM, Tlalnepantla, México.
  • Terry Fox National Tumor Bank, Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Nutrition, Genetics and Metabolism Research Group, Faculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
  • Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

ORCID-Profile: Carlos Castro-Rojas, Felipe Vaca-Paniagua

Förderung

  • World Health Organization
  • UNAM PAPIIT
  • CONACYT Fondo Sectorial
  • Fondo SEP CONACYT
  • IARC-WHO

Zitieren

APA

Ambriz-Barrera, F., Rojas-Jiménez, E., Díaz-Velásquez, C. E., De-La-Cruz-Montoya, A. H., Martínez-Gregorio, H., Ruiz-De-La-Cruz, M., Huertas, A., Montealegre, A. L., Castro-Rojas, C., Acosta, G., Vaca-Paniagua, F., & Perdomo, S. (2024). Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0308176

Vancouver

Ambriz-Barrera F, Rojas-Jiménez E, Díaz-Velásquez CE, De-La-Cruz-Montoya AH, Martínez-Gregorio H, Ruiz-De-La-Cruz M, et al. Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0308176

BibTeX
@article{AmbrizBarrera2024,
  author = {Ambriz-Barrera, Fernando and Rojas-Jiménez, Ernesto and Díaz-Velásquez, Clara Estela and De-La-Cruz-Montoya, Aldo Hugo and Martínez-Gregorio, Héctor and Ruiz-De-La-Cruz, Miguel and Huertas, Antonio and Montealegre, Ana Lorena and Castro-Rojas, Carlos and Acosta, Gabriela and Vaca-Paniagua, Felipe and Perdomo, Sandra},
  title = {Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0308176}
}
Kostenlos starten →